Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920199's OCF Margin % is ranked worse than 55.79% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: 5.685
vs BJSE:920199: 2.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SiChuan Qian Li Beoka Medical Technology Co OCF Margin % Chart
SiChuan Qian Li Beoka Medical Technology Co Annual Data
BJSE:920199 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, SiChuan Qian Li Beoka Medical Technology Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SiChuan Qian Li Beoka Medical Technology Co OCF Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) has a OCF Margin % of -29.10% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. According to the industry distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #453 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 55.8%.
Is SiChuan Qian Li Beoka Medical Technology Co's OCF Margin % too high?
SiChuan Qian Li Beoka Medical Technology Co's current OCF Margin % is -29.10%. Based on the distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #453 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SiChuan Qian Li Beoka Medical Technology Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SiChuan Qian Li Beoka Medical Technology Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #453 out of 812 companies for OCF Margin %. This places SiChuan Qian Li Beoka Medical Technology Co in the lower half of its industry. The industry median OCF Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.69, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SiChuan Qian Li Beoka Medical Technology Co's current OCF Margin % is -29.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SiChuan Qian Li Beoka Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.97, compared to a current price of ¥27.12 — trading 50.9% above its estimated fair value. The current OCF Margin % is -29.10%. SiChuan Qian Li Beoka Medical Technology Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199), the current OCF Margin % is -29.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Overvalued in 2026?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co stock appears to be overvalued.
The current stock price of ¥27.12 is trading 50.9% above its estimated GF Value™ of ¥17.97.
GuruFocus considers SiChuan Qian Li Beoka Medical Technology Co to be Significantly Overvalued.
Key valuation signals for BJSE:920199:
OCF Margin %: -29.10%
GF Value™: ¥17.97 vs. price of ¥27.12 (50.9% above fair value)
No single metric tells the full story. See the BJSE:920199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SiChuan Qian Li Beoka Medical Technology Co Ltd is an intelligent rehabilitation equipment manufacturer integrating research, development, production, sales, and service. Its product series comprises the Electrotherapy series, Heat therapy series, Force therapy series, Spa series, and Oxygen therapy series.
57GF Score
Get the complete analysis for BJSE:920199
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920199 has been successfully added to your 
